Literature DB >> 10992487

Lectin site interaction with capsular polysaccharide mediates nonimmune phagocytosis of type III group B streptococci.

E A Albanyan1, M S Edwards.   

Abstract

Group B Streptococcus (GBS) causes substantial morbidity but most individuals exposed to the organism remain healthy. These experiments tested the hypothesis that engagement of the complement receptor 3 (CR3) lectin site would effectively trigger neutrophil-mediated phagocytosis of complement-opsonized type III GBS by nonimmune human sera. Using an opsonophagocytosis assay, saccharides identified as interacting with the CR3 lectin site effectively inhibited neutrophil-mediated killing of type III, strain COH1. Fructose, which does not interact with the lectin site, promoted significantly less inhibition of opsonophagocytosis. Saccharide-mediated inhibition was reversed in a dose-related fashion by addition of type III, GBS capsular polysaccharide-specific immunoglobulin G. When capsule-deficient or asialo mutant type III strains were employed, the lectin site was not required. Structurally defined GBS serotypes with a side chain at least two sugars in length engaged the lectin site, and N-acetyl D-glucosamine was not a required component monosaccharide. Intact type III capsular polysaccharide interacted significantly more efficiently with the lectin site than did oligosaccharides representing approximately 5 or 20 repeating units, respectively. Taken together, these experiments indicate that interaction of type III GBS capsular polysaccharide with the lectin site of CR3 effects phagocytosis of these organisms by nonimmune serum. Use of this mechanism of innate immunity provides a potential explanation for the infrequency with which susceptible individuals exposed to type III GBS develop invasive infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10992487      PMCID: PMC101539          DOI: 10.1128/IAI.68.10.5794-5802.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  Conformational epitope of the type III group B Streptococcus capsular polysaccharide.

Authors:  W Zou; R Mackenzie; L Thérien; T Hirama; Q Yang; M A Gidney; H J Jennings
Journal:  J Immunol       Date:  1999-07-15       Impact factor: 5.422

2.  Nonopsonic binding of type III Group B Streptococci to human neutrophils induces interleukin-8 release mediated by the p38 mitogen-activated protein kinase pathway.

Authors:  E A Albanyan; J G Vallejo; C W Smith; M S Edwards
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

3.  Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells.

Authors:  V Vetvicka; B P Thornton; G D Ross
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

4.  Characterization of mannose receptor-dependent phagocytosis mediated by Mycobacterium tuberculosis lipoarabinomannan.

Authors:  B K Kang; L S Schlesinger
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

5.  Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus.

Authors:  M S Edwards; C J Baker; D L Kasper
Journal:  J Infect Dis       Date:  1979-12       Impact factor: 5.226

6.  Structural determination and serology of the native polysaccharide antigen of type-III group B Streptococcus.

Authors:  H J Jennings; K G Rosell; D L Kasper
Journal:  Can J Biochem       Date:  1980-02

Review 7.  Group B streptococcus.

Authors:  A Schuchat
Journal:  Lancet       Date:  1999-01-02       Impact factor: 79.321

8.  Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection.

Authors:  C J Baker; D L Kasper
Journal:  N Engl J Med       Date:  1976-04-01       Impact factor: 91.245

Review 9.  Epidemiology of group B streptococcal disease in the United States: shifting paradigms.

Authors:  A Schuchat
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

10.  The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus.

Authors:  M S Edwards; A Nicholson-Weller; C J Baker; D L Kasper
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

View more
  7 in total

1.  Phylogenetic lineage and pilus protein Spb1/SAN1518 affect opsonin-independent phagocytosis and intracellular survival of Group B Streptococcus.

Authors:  Debasish Chattopadhyay; Alison J Carey; Elise Caliot; Richard I Webb; James R Layton; Yan Wang; John F Bohnsack; Elisabeth E Adderson; Glen C Ulett
Journal:  Microbes Infect       Date:  2011-01-14       Impact factor: 2.700

Review 2.  Intrinsic Maturational Neonatal Immune Deficiencies and Susceptibility to Group B Streptococcus Infection.

Authors:  Michelle L Korir; Shannon D Manning; H Dele Davies
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

3.  Staphylococcus epidermidis Bacteremia Induces Brain Injury in Neonatal Mice via Toll-like Receptor 2-Dependent and -Independent Pathways.

Authors:  Dan Bi; Lili Qiao; Ilana Bergelson; C Joakim Ek; Luqi Duan; Xiaoli Zhang; Anna-Maj Albertsson; Matthew Pettengill; Kenny Kronforst; Jana Ninkovic; Donald Goldmann; Anders Janzon; Henrik Hagberg; Xiaoyang Wang; Carina Mallard; Ofer Levy
Journal:  J Infect Dis       Date:  2015-04-15       Impact factor: 5.226

4.  Chemical Synthesis of the Repeating Unit of Type V Group B Streptococcus Capsular Polysaccharide.

Authors:  Jian Gao; Zhongwu Guo
Journal:  Org Lett       Date:  2016-10-19       Impact factor: 6.005

5.  TLR2 mediates recognition of live Staphylococcus epidermidis and clearance of bacteremia.

Authors:  Tobias Strunk; Melanie R Power Coombs; Andrew J Currie; Peter Richmond; Douglas T Golenbock; Liat Stoler-Barak; Leighanne C Gallington; Michael Otto; David Burgner; Ofer Levy
Journal:  PLoS One       Date:  2010-04-09       Impact factor: 3.240

6.  Role of macrophages in host resistance to group A streptococci.

Authors:  Oliver Goldmann; Manfred Rohde; Gursharan Singh Chhatwal; Eva Medina
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

7.  Critical role of the complement system in group B streptococcus-induced tumor necrosis factor alpha release.

Authors:  Ofer Levy; Rochelle M Jean-Jacques; Colette Cywes; Richard B Sisson; Kol A Zarember; Paul J Godowski; Jennifer L Christianson; Hilde-Kari Guttormsen; Michael C Carroll; Anne Nicholson-Weller; Michael R Wessels
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.